CoChat

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

No increase in new users of blood glucose-lowering drugs in Norway 2006–2011: a nationwide prescription database study

Open access

Abstract

BACKGROUND: National estimates for the occurrence of diabetes are difficult to obtain, particularly time trends in incidence. The aim was to describe time trends in prevalent and incident use of blood glucose-lowering drugs by age group and gender in Norway during 2005-2011. METHODS: Data were obtained from the nationwide Norwegian Prescription Database. We defined prevalent users of "insulins only" as individuals having no oral antidiabetic drugs (OAD) dispensed from a pharmacy during the previous 24 months or in the subsequent 12 months. Incident users had no blood glucose-lowering drugs dispensed in the previous 24 months; incident "insulins only" users also had no OAD in the subsequent 12 months. RESULTS: In 2011, 3.2% of the population had blood glucose-lowering drugs dispensed, and the incidence rate was 313 per 100,000 person years. The prevalence of OAD use increased from 1.8% in 2005 to 2.4% in 2011; however a decreasing trend in incidence of OAD use was observed, particularly in those aged 70 years and older. In 2010, 0.64% of the population had insulins only dispensed, with an overall incidence rate in the total population of 33 per 100,000 person years which was stable over time. CONCLUSIONS: In this nationwide study, we found that although the prevalent use of OAD had increased in recent years, incident use was stable or had decreased. This may indicate that the increase in diabetes occurrence in Norway is levelling off, at least temporarily.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2458-14-520

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow chart illustrating the definitions used for classifying subjects as (a) prevalent and (b) incident users of any blood glucose-lowering drug, OAD and insulins only. Figures for 2010 are shown.
Figure 1 Flow chart illustrating the definitions used for classifying subjects as (a) prevalent and (b) incident users of any blood glucose-lowering drug, OAD and insulins only. Figures for 2010 are shown.CC BY · PubMed Central
Figure 2 Prevalent use of blood glucose-lowering drugs by age and gender in Norway in 2010. Solid lines: any blood glucose-lowering drug (A10). Dashed lines, oral antidiabetic drugs. Short dashed lines: insulins only; i.e. individuals having insulins dispensed in 2010, but no OAD in the previous 24 months or in the subsequent 12 months after the first prescription filled.
Figure 2 Prevalent use of blood glucose-lowering drugs by age and gender in Norway in 2010. Solid lines: any blood glucose-lowering drug (A10). Dashed lines, oral antidiabetic drugs. Short dashed lines: insulins only; i.e. individuals having insulins dispensed in 2010, but no OAD in the previous 24 months or in the subsequent 12 months after the first prescription filled.CC BY · PubMed Central
Figure 3 Time trends in prevalence of OAD (A10B) use by 10 year age groups in (a) men and (b) women.
Figure 3 Time trends in prevalence of OAD (A10B) use by 10 year age groups in (a) men and (b) women.CC BY · PubMed Central
Figure 4 Incident use of blood glucose-lowering drugs by age and gender in Norway. Incident use is defined as no use of blood glucose-lowering drugs in the previous 24 months. (a) OAD (A10B); period 2006–2011. (b) Insulins and analogues (A10A); period 2006–2010. No OAD dispensed in the subsequent 12 months.
Figure 4 Incident use of blood glucose-lowering drugs by age and gender in Norway. Incident use is defined as no use of blood glucose-lowering drugs in the previous 24 months. (a) OAD (A10B); period 2006–2011. (b) Insulins and analogues (A10A); period 2006–2010. No OAD dispensed in the subsequent 12 months.CC BY · PubMed Central
Figure 5 Time trends in incident use of blood glucose-lowering drugs in Norway. Incident defined as no use of blood glucose-lowering drugs in the previous 24 months. In addition for incident use of insulins only, no OAD dispensed in the subsequent 12 months. (a) Incident use of OAD (A10B) in men (b) Incident use of OAD in women. (c) Incident use of insulins only (A10A) in men (d) Incident use of insulins only in women.
Figure 5 Time trends in incident use of blood glucose-lowering drugs in Norway. Incident defined as no use of blood glucose-lowering drugs in the previous 24 months. In addition for incident use of insulins only, no OAD dispensed in the subsequent 12 months. (a) Incident use of OAD (A10B) in men (b) Incident use of OAD in women. (c) Incident use of insulins only (A10A) in men (d) Incident use of insulins only in women.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 3

  1. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC Classification and DDD assignment: Oslo, 2012. WHO Collaborating Centre for Drug Statistics Methodology. 2013, Norwegian Institute of Public Health, (available from: http://www.whocc.no/filearchive/publications/1_2013guidelines.pdf )
  2. WHO Collaborating Centre for Drug Statistics Methodology, ATC classification index with DDDs: Oslo, 2012. WHO Collaborating Centre for Drug Statistics Methodology. 2013, Norwegian Institute of Public Health, (available from: http://www.whocc.no/atc_ddd_publications/atc_ddd_index/ )
  3. Gudbjornsdottir S, Eliasson B, Cederholm J, Zethelius B, Svensson AM, Samuelsson P: Annual Report of the Swedish Diabetes Register, 2011 [In Swedish]. 2012, The Swedish Diabetes Register, available from: https://www.ndr.nu/pdf/NDR_rapport2011_LR.pdf

Cited by

See all 39

Metadata

Authors
Strøm, H., Selmer, R., Birkeland, K. I., Schirmer, H., Berg, T. J., Jenum, A. K., Midthjell, K., Berg, C., & Stene, L. C.
Affiliations
  • Norwegian Institute of Public Health (NO)
  • Oslo University Hospital (NO)
  • University Hospital of North Norway (NO)
  • OsloMet – Oslo Metropolitan University (NO)
  • Norwegian University of Science and Technology (NO)
Corresponding author
Strøm, Hanne
Venue
BMC Public Health
Published
2014-05-29
Volume
14
Issue
1
Pages
520-520
ISSN
1471-2458 (ISSN-L)
OpenAlex
W2108017238
Cited by
39
References
19
Citations by year
2025: 1 · 2024: 2 · 2022: 4 · 2021: 4 · 2020: 1 · 2019: 6 · 2018: 5 · 2017: 3 · 2016: 8 · 2015: 2 · 2014: 3
FWCI
4.29
Type
journal article
Language
en
Open access
Locations
  • BMC Public Health (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • BIBSYS Brage (BIBSYS (Norway)) (submittedVersion)
  • NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
  • NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
Funders
Diabetesforbundet
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
diabetes mellitus, oral antidiabetic drugs, insulin, incidence trends, prevalence, temporal trends, age and gender differences, older adults, medication dispensing, Norway
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Diabetes Mellitus, Female, Humans, Hyperglycemia, Hypoglycemic Agents, Infant, Insulin, Male, Middle Aged, Norway, Drug Prescriptions, Databases, Factual, Age Distribution, Sex Distribution, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: No increase in new users of blood glucose-lowering drugs in Norway 2006–2011: a nationwide prescription database study. https://app.cochat.ai/papers/10.1186/1471-2458-14-520
The paper
Strøm, H., Selmer, R., Birkeland, K. I., Schirmer, H., Berg, T. J., Jenum, A. K., Midthjell, K., Berg, C., & Stene, L. C. (2014). No increase in new users of blood glucose-lowering drugs in Norway 2006–2011: a nationwide prescription database study. BMC Public Health. https://doi.org/10.1186/1471-2458-14-520

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.